You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

double-masked

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thyroid Eye Disease Trial (VRDN-001 10 mg/kg Drug:)

Not yet recruiting
  • Thyroid Eye Disease
  • VRDN-001 10 mg/kg Drug:
  • (no location specified)
Sep 7, 2023

Corneal Edema, Corneal Endothelial Dysfunction Trial (AURN001)

Not yet recruiting
  • Corneal Edema
  • Corneal Endothelial Dysfunction
  • AURN001
  • (no location specified)
Sep 11, 2023

Atopic Asthma Trial in Mississauga (ADX-629, Placebo)

Completed
  • Atopic Asthma
  • Mississauga, Ontario, Canada
    Cliantha Research
Jan 9, 2023

Dry Eye Disease Trial in Andover (Reproxalap Ophthalmic Solution (0.25%), Placebo Comparator)

Completed
  • Dry Eye Disease
  • Reproxalap Ophthalmic Solution (0.25%)
  • Placebo Comparator
  • Andover, Massachusetts
    Andover Eye Associates
Jan 24, 2023

Diabetic Macular Edema, Diabetic Retinopathy Trial (4D-150 IVT, Aflibercept IVT)

Not yet recruiting
  • Diabetic Macular Edema
  • Diabetic Retinopathy
  • 4D-150 IVT
  • Aflibercept IVT
  • (no location specified)
Jun 26, 2023

Open Angle Glaucoma Trial (NCX 470, Placebo)

Not yet recruiting
  • Open Angle Glaucoma
  • NCX 470
  • Placebo
  • (no location specified)
Jul 6, 2023

Retinitis Pigmentosa Trial (2C-QD, Sham 2C-QD)

Not yet recruiting
  • Retinitis Pigmentosa
  • 2C-QD
  • (no location specified)
Apr 24, 2023

Diabetic Macular Edema Trial (EYP-1901, Aflibercept 2Mg/0.05Ml Inj,Oph)

Not yet recruiting
  • Diabetic Macular Edema
  • (no location specified)
Oct 19, 2023

Retinal Disease Trial in Round Rock (IRX-101, Providone-Iodine)

Recruiting
  • Retinal Disease
  • Round Rock, Texas
    Edward Wood, MD
Mar 1, 2023

Visual Stress Trial in Cambridge (Tinted Lenses)

Recruiting
  • Visual Stress
  • Tinted Lenses
  • Cambridge, United Kingdom
    Anglis Ruskin University
Oct 19, 2023

Glaucoma, Open-Angle Trial in Durham (VVN539 Ophthalmic Solution 0.02%, VVN539 Ophthalmic Solution 0.04%, VVN539 Ophthalmic

Recruiting
  • Glaucoma, Open-Angle
  • VVN539 Ophthalmic Solution 0.02%
  • +2 more
  • Durham, North Carolina
    Lexitas
Jul 19, 2022

Retinal Disease Trial in San Antonio (IRX-101, Providone-Iodine)

Recruiting
  • Retinal Disease
  • San Antonio, Texas
    R. Gary Lane, II MD
Mar 1, 2023

Dry Eye Disease Trial (TL-925, Placebo)

Not yet recruiting
  • Dry Eye Disease
  • (no location specified)
Feb 22, 2023

Geographic Atrophy Trial in Huntington Beach, Hagerstown (Tinlarebant, Placebo)

Recruiting
  • Geographic Atrophy
  • Huntington Beach, California
  • +1 more
Jul 21, 2023

Neovascular Age-related Macular Degeneration Trial in Suzhou (Aflibercept Ophthalmic, IBI302)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • Aflibercept Ophthalmic
  • IBI302
  • Suzhou, Jiangsu, China
    Innovent Biologics (Suzhou) Co,Ltd.
Jul 25, 2023

Allergic Conjunctivitis Trial in Andover (TL-925, Placebo)

Recruiting
  • Allergic Conjunctivitis
  • Andover, Massachusetts
    Andover Eye Associates
Nov 29, 2023

Dry Eye Disease Trial in Venice (Varenicline solution, Placebo nasal spray (OC-01 Vehicle Nasal Spray))

Recruiting
  • Dry Eye Disease
  • Varenicline solution
  • Placebo nasal spray (OC-01 Vehicle Nasal Spray)
  • Venice, Florida
    Stephenson Eye Associates
Aug 23, 2022

Wet Age-related Macular Degeneration Trial in Beijing (RC28-E, Aflibercept)

Recruiting
  • Wet Age-related Macular Degeneration
  • Beijing, Beijing, China
    Beijing Hospital
Feb 3, 2023

Multiple Sclerosis Trial in Moscow (BCD-132, Teriflunomide)

Recruiting
  • Multiple Sclerosis
  • Moscow, Russian Federation
    State Budgetary Healthcare Institution of the Moscow Region M.F.
May 18, 2022

Thyroid Eye Disease Trial in Shanghai (IBI311, )

Recruiting
  • Thyroid Eye Disease
  • IBI311
  • placebo
  • Shanghai, Shanghai, China
    Shanghai Ninth People's Hospital, Shanghai JiaoTong University S
Mar 20, 2023

Age-Related Macular Degeneration Trial (Active Comparator CT1812, Placebo Comparator)

Not yet recruiting
  • Age-Related Macular Degeneration
  • Active Comparator CT1812
  • Placebo Comparator
  • (no location specified)
Jun 5, 2023

Uveitis Posterior Non-Infectious, Uveitis, Intermediate, Noninfectious Panuveitis Trial in Waltham, Erie (ESK-001)

Recruiting
  • Uveitis Posterior Non-Infectious
  • +2 more
  • Waltham, Massachusetts
  • +1 more
Jul 18, 2023

Myopia, Progressive Trial (IVMED 85, Placebo)

Not yet recruiting
  • Myopia, Progressive
  • IVMED 85
  • Placebo
  • (no location specified)
Mar 7, 2023

Dry Age-related Macular Degeneration Trial (QA102/Placebo, QA102, Placebo)

Not yet recruiting
  • Dry Age-related Macular Degeneration
  • QA102/Placebo
  • +2 more
  • (no location specified)
Sep 8, 2022

Eye Diseases Trial in Vienna (Laquinimod, Placebo)

Recruiting
  • Eye Diseases
  • Vienna, Austria
    Clinical trial center at Medical University Vienna
Aug 9, 2022